Gustavo A. Rosario Benitez

Array ( [id] => 4976833 [patent_doc_number] => 20070218064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'HUMAN ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES' [patent_app_type] => utility [patent_app_number] => 11/617503 [patent_app_country] => US [patent_app_date] => 2006-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 41808 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218064.pdf [firstpage_image] =>[orig_patent_app_number] => 11617503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5159439 [patent_doc_number] => 20070172483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Methods for treating conditions associated with MASP-2 dependent complement activation' [patent_app_type] => utility [patent_app_number] => 11/645359 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 72950 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172483.pdf [firstpage_image] =>[orig_patent_app_number] => 11645359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5354731 [patent_doc_number] => 20090186075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Composition' [patent_app_type] => utility [patent_app_number] => 12/086736 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8063 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186075.pdf [firstpage_image] =>[orig_patent_app_number] => 12086736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792096 [patent_doc_number] => 20080293070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Markers for Memory T Cells and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/158201 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 18550 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293070.pdf [firstpage_image] =>[orig_patent_app_number] => 12158201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5405887 [patent_doc_number] => 20090241202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'DOMAIN-GRAFTED ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/095822 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15110 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20090241202.pdf [firstpage_image] =>[orig_patent_app_number] => 12095822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253293 [patent_doc_number] => 20070134749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Protein tyrosine kinase substrate lat and its use in the identification of (ANT)agonists of the kinase' [patent_app_type] => utility [patent_app_number] => 11/607719 [patent_app_country] => US [patent_app_date] => 2006-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 32201 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134749.pdf [firstpage_image] =>[orig_patent_app_number] => 11607719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758896 [patent_doc_number] => 20080311122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/094449 [patent_app_country] => US [patent_app_date] => 2006-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 72445 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311122.pdf [firstpage_image] =>[orig_patent_app_number] => 12094449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751945 [patent_doc_number] => 20080160018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Humanized immunoglobulins' [patent_app_type] => utility [patent_app_number] => 11/603273 [patent_app_country] => US [patent_app_date] => 2006-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 61534 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160018.pdf [firstpage_image] =>[orig_patent_app_number] => 11603273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284420 [patent_doc_number] => 20090098095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'METHOD OF EXPANDING DOUBLE NEGATIVE T CELLS' [patent_app_type] => utility [patent_app_number] => 12/093492 [patent_app_country] => US [patent_app_date] => 2006-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7778 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098095.pdf [firstpage_image] =>[orig_patent_app_number] => 12093492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10136148 [patent_doc_number] => 09169461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-27 [patent_title] => 'Use of apoptotic cells ex vivo to generate regulatory T cells' [patent_app_type] => utility [patent_app_number] => 11/579319 [patent_app_country] => US [patent_app_date] => 2006-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 9676 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11579319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4999324 [patent_doc_number] => 20070041958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/585926 [patent_app_country] => US [patent_app_date] => 2006-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21332 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20070041958.pdf [firstpage_image] =>[orig_patent_app_number] => 11585926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7801231 [patent_doc_number] => 08129503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Agents that bind a target in pulmonary tissue for targeting respiratory diseases' [patent_app_type] => utility [patent_app_number] => 12/084084 [patent_app_country] => US [patent_app_date] => 2006-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 94 [patent_no_of_words] => 47957 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/129/08129503.pdf [firstpage_image] =>[orig_patent_app_number] => 12084084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5302888 [patent_doc_number] => 20090297540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Induction of Indoleamine 2,3-Dioxygenase in Dendritic Cells by TLR Ligands and Uses thereof' [patent_app_type] => utility [patent_app_number] => 12/083855 [patent_app_country] => US [patent_app_date] => 2006-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14313 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297540.pdf [firstpage_image] =>[orig_patent_app_number] => 12083855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5569305 [patent_doc_number] => 20090252683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Composition Comprising Cross-Species-Sepecific Antibodies and uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/083351 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 35498 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20090252683.pdf [firstpage_image] =>[orig_patent_app_number] => 12083351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5040238 [patent_doc_number] => 20070092520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Humanized Anti-CMET Antagonists' [patent_app_type] => utility [patent_app_number] => 11/537760 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 39948 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092520.pdf [firstpage_image] =>[orig_patent_app_number] => 11537760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219289 [patent_doc_number] => 20070160600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations' [patent_app_type] => utility [patent_app_number] => 11/541958 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 29583 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20070160600.pdf [firstpage_image] =>[orig_patent_app_number] => 11541958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4538340 [patent_doc_number] => 07875427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-25 [patent_title] => 'Compositions and methods for IL-13 biomarkers' [patent_app_type] => utility [patent_app_number] => 11/536704 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3361 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/875/07875427.pdf [firstpage_image] =>[orig_patent_app_number] => 11536704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5204510 [patent_doc_number] => 20070025990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Methods of administering/dosing CD2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders' [patent_app_type] => utility [patent_app_number] => 11/541237 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66380 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20070025990.pdf [firstpage_image] =>[orig_patent_app_number] => 11541237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10038148 [patent_doc_number] => 09078843 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Immunogenic fragments of T-cell receptor constant domains and peptides derived therefrom' [patent_app_type] => utility [patent_app_number] => 12/067652 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 25 [patent_no_of_words] => 27039 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12067652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4988148 [patent_doc_number] => 20070154487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Compositions and methods for modulation of RORgammat functions' [patent_app_type] => utility [patent_app_number] => 11/524501 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 51551 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154487.pdf [firstpage_image] =>[orig_patent_app_number] => 11524501 [rel_patent_id] =>[rel_patent_doc_number] =>)